Page last updated: 2024-09-05

sb 203580 and dimethylarginine

sb 203580 has been researched along with dimethylarginine in 1 studies

Compound Research Comparison

Studies (sb 203580)	Trials (sb 203580)	Recent Studies (post-2010) (sb 203580)	Studies (dimethylarginine)	Trials (dimethylarginine)	Recent Studies (post-2010) (dimethylarginine)
3,489	4	1,137	519	53	244

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, YX; Jian, D; Li, J; Li, WZ; Shi, W; Wang, B; Xie, HF	1

Other Studies

1 other study(ies) available for sb 203580 and dimethylarginine

Article	Year
Asymmetrical dimethylarginine promotes the senescence of human skin fibroblasts via the activation of a reactive oxygen species-p38 MAPK-microRNA-138 pathway. Journal of dermatological science, 2015, Volume: 78, Issue:2 Topics: Acetylcysteine; Arginine; Back; Cells, Cultured; Cellular Senescence; Child; Enzyme Inhibitors; Face; Fibroblasts; Free Radical Scavengers; Humans; Imidazoles; MAP Kinase Signaling System; MicroRNAs; Middle Aged; Pyridines; Reactive Oxygen Species; Skin; Skin Aging; Ultraviolet Rays	2015

Article

Year

Asymmetrical dimethylarginine promotes the senescence of human skin fibroblasts via the activation of a reactive oxygen species-p38 MAPK-microRNA-138 pathway.

Journal of dermatological science, 2015, Volume: 78, Issue:2

Topics: Acetylcysteine; Arginine; Back; Cells, Cultured; Cellular Senescence; Child; Enzyme Inhibitors; Face; Fibroblasts; Free Radical Scavengers; Humans; Imidazoles; MAP Kinase Signaling System; MicroRNAs; Middle Aged; Pyridines; Reactive Oxygen Species; Skin; Skin Aging; Ultraviolet Rays

2015